Zobrazeno 1 - 10
of 902
pro vyhledávání: '"psychotropic agent"'
Publikováno v:
Frontiers in Psychiatry, Vol 14 (2024)
BackgroundOptimal use of psychotropic medications for people living with dementia is important. By finding potentially modifiable factors, dementia care teams may find solutions to achieve the appropriate use of psychotropic drugs.ObjectiveThis study
Externí odkaz:
https://doaj.org/article/5f6dd075c0cc488dbd2c08646554a1b5
Publikováno v:
Journal of Clinical Interventional Radiology ISVIR, Vol 6, Iss 01, Pp 23-27 (2022)
Objectives Acute pain management in opioid users can be challenging in the perioperative period. This study focuses on whether use of opioids increases sedation medication requirements in patients undergoing port placement under moderate sedation. Ma
Autor:
Melanie Bischoff, Andreas Redel
Publikováno v:
AINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie. 56:691-702
ZusammenfassungEtwa ein Drittel aller Patienten, die sich einem operativen Eingriff unterziehen, nehmen chronisch Psychopharmaka ein. Neben Depressionen und Psychosen stellen chronische Schmerzen sowie Angst- und Panikstörungen die häufigsten Indik
Publikováno v:
ASSAY and Drug Development Technologies. 19:373-385
Recent reports have highlighted the possible role of the antipsychotic chlorpromazine and the antidepressant fluvoxamine as anti-coronavirus disease 2019 (COVID-19) agents. The objective of this narrative review is to explore what is known about the
Publikováno v:
Indian Journal of Psychological Medicine. 45:14-18
Introduction: Sialorrhoea, or excessive salivation, is common in psychiatric patients. This can be distressing because of its physical and psychosocial complications. Sialorrhoea due to psychotropic drugs has been reported repeatedly in the literatur
Autor:
Kamil Mika, Agnieszka Cios, Agata Siwek, Anna Partyka, Adam Bucki, Magdalena Kotańska, Nikola Fajkis-Zajączkowska, Anna Wesołowska, Monika Głuch-Lutwin, Paweł Żmudzki, Michał Abram, Paweł Mierzejewski, Monika Marcinkowska, Marcin Kołaczkowski, Magdalena Jastrzębska-Więsek, Joanna Sniecikowska, Elżbieta Wyska, Katarzyna Przejczowska-Pomierny, Agnieszka Zagórska
Publikováno v:
Journal of Medicinal Chemistry
The current pharmaceutical market lacks therapeutic agents designed to modulate behavioral disturbances associated with dementia. To address this unmet medical need, we designed multifunctional ligands characterized by a nanomolar affinity for clinic
Publikováno v:
The Mental Health Clinician
Clozapine is recognized as the drug of choice for treatment-refractory schizophrenia, but use may be limited because of strict monitoring requirements and adverse effects including severe neutropenia, seizures, and myocarditis. Loxapine is a first-ge
Autor:
Madison N. Irwin, Amy VandenBerg
Publikováno v:
The Mental Health Clinician
IntroductionMDD represents a significant burden worldwide, and while a number of approved treatments exist, there are high rates of treatment resistance and refractoriness. Ketamine, an N-methyl-d-aspartate receptor (NMDAR) antagonist, is a novel, ra
Autor:
Neeru Mittal, Bharti Thakur
Publikováno v:
International Annals of Criminology. 59:88-97
The Narcotic Drugs and Psychotropic Substances Act, or NDPS Act, was enacted to control addictive drugs and prohibit their possession, dispersion, sale, import, and trade in India. Psychotropic agents have the potential to change an individual’s co
Publikováno v:
Drug Development and Industrial Pharmacy. 47:542-551
Risperidone is a potent psychotropic agent has been approved for symptomatic treatment of irritability in children and adolescents with autism spectrum disorders. However, its bitter taste and dose adjustment of liquid dosage forms are a main hurdle